title: [Does infusion therapy in trained patients with intermittent claudication have advantages?].
authors.affiliation: Medizinische Universitätsklinik Heidelberg.
authors.forename: T
authors.initials: T
authors.lastname: Weiss
authors.forename: C
authors.initials: C
authors.lastname: Wilhelm
authors.forename: C
authors.initials: C
authors.lastname: Hübsch-Müller
authors.forename: E
authors.initials: E
authors.lastname: Hsu
authors.forename: C
authors.initials: C
authors.lastname: Diehm
mesh_terms: D000527:Alprostadil / Q000008:administration & dosage*; D005080:Exercise Test / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D007383:Intermittent Claudication / Q000188:drug therapy*; D009257:Nafronyl / Q000008:administration & dosage*
chemical_list: D009257:Nafronyl; D000527:Alprostadil
vernacular_title: Bringt eine Infusionstherapie bei austrainierten Patienten mit Claudicatio intermittens Vorteile?